Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Immunodeficiency Virus-Type 1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05383456
What this trial is testing

The Visceral Adiposity Measurement and Observation Study

Who this might be right for
HIVHIV-InfectionsHIV-1-infection+16 more
Theratechnologies 196
Early research (Phase 1)Study completedNCT00412477
What this trial is testing

A Phase I Study of Safety and Immunogenicity of the WRAIR HIV-1 Vaccine

Who this might be right for
HIV Infections
U.S. Army Medical Research and Development Command 18
Testing effectiveness (Phase 2)Study completedNCT00120185
What this trial is testing

Efficacy of Using Interleukin-2 in Antiretroviral Naïve HIV Patients (ANRS119)

Who this might be right for
HIV Infections
French National Agency for Research on AIDS and Viral Hepatitis 130
Post-approval studies (Phase 4)UnknownNCT04225325
What this trial is testing

Implication for Strategies of Long Term Control of Viral Replication in Patient With Primary HIV Infection (PHI).

Who this might be right for
HIV-1-infection
ADRIANO LAZZARIN, MD 112
Not applicableStudy completedNCT00001121
What this trial is testing

Monitor the Health of Participants in HIVNET 014 Who Become Infected With HIV-1

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Testing effectiveness (Phase 2)Study completedNCT00002184
What this trial is testing

A Phase II, Stratified, Randomized, Double-Blind, Multi-Center Study of the Safety and Efficacy of Adefovir Dipivoxil (ADF) at Two Dose Levels in Triple Combination Therapies With Protease Inhibitors (PI) and Nucleoside Reverse Transcriptase Inhibitors (RTI) for the Treatment of HIV-Infected Patient

Who this might be right for
HIV Infections
Gilead Sciences 120
Not applicableStudy completedNCT03624413
What this trial is testing

InTSHA: Interactive Transition Support for HIV-infected Adolescents Using Social Media

Who this might be right for
HIV-1-infectionAdolescent Behavior
Emory University 80
Testing effectiveness (Phase 2)Study completedNCT00126880
What this trial is testing

AVX754 (a New Nucleoside Reverse Transcriptase Inhibitor [NRTI]) to Treat Drug-resistant HIV

Who this might be right for
HIV Infections
Avexa 52
Early research (Phase 1)Study completedNCT05261191
What this trial is testing

MGD020 Alone or Combined With MGD014 in Persons With HIV-1 on Antiretroviral Therapy

Who this might be right for
Human Immunodeficiency Virus I InfectionImmunodeficiency Virus Type 1, HumanHuman Immunodeficiency Virus Type 1
MacroGenics 17
Testing effectiveness (Phase 2)Ended earlyNCT00002420
What this trial is testing

The Safety and Effectiveness of Didanosine Plus Stavudine Plus Delavirdine Mesylate Plus MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease Inhibitors

Who this might be right for
HIV Infections
Bristol-Myers Squibb 25
Not applicableUnknownNCT05137210
What this trial is testing

Identifying Efficient Linkage Strategies for Men

Who this might be right for
Hiv
University of California, Los Angeles 569
Testing effectiveness (Phase 2)Study completedNCT00887120
What this trial is testing

Dose Reduction of Lopinavir in Children

Who this might be right for
HIV Infections
The HIV Netherlands Australia Thailand Research Collaboration 24
Not applicableStudy completedNCT00102986
What this trial is testing

Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 116
Not applicableStudy completedNCT04417946
What this trial is testing

Peer-led Social Media Intervention to Prevent HIV Among Young Men Who Have Sex With Men (YMSM)

Who this might be right for
Pre-Exposure ProphylaxisHivMen
Yale University 227
Large-scale testing (Phase 3)Study completedNCT00002124
What this trial is testing

A Double-Blind, Randomized, Dose Response Study of Three Doses of Delavirdine Mesylate (U-90152S) in Combination With Zidovudine (ZDV) Versus ZDV Alone in HIV-1 Infected Individuals With CD4 Counts of 200-500mm3

Who this might be right for
HIV Infections
Pharmacia and Upjohn 1,250
Large-scale testing (Phase 3)Active Not RecruitingNCT02881320
What this trial is testing

Study of Bictegravir/Emtricitabine/Tenofovir Alafenamide Fixed Dose Combination in Adolescents and Children With Human Immunodeficiency Virus-1

Who this might be right for
HIV-1 Infection
Gilead Sciences 177
Large-scale testing (Phase 3)Study completedNCT04618198
What this trial is testing

Early Empiric Anti-Mycobacterium Tuberculosis Therapy for Sepsis in Sub-Saharan Africa

Who this might be right for
TuberculosisHIV I InfectionSepsis
University of Virginia 437
Early research (Phase 1)Study completedNCT00705926
What this trial is testing

Effectiveness of Antiretroviral Therapy During Acute HIV Infection

Who this might be right for
HIV Infections
Massachusetts General Hospital 25
Testing effectiveness (Phase 2)Study completedNCT01302847
What this trial is testing

Safety of and Immune Response to Dolutegravir in HIV-1 Infected Infants, Children, and Adolescents

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 181
Large-scale testing (Phase 3)Study completedNCT00398684
What this trial is testing

Nevirapine Plus Zidovudine to Prevent Perinatal HIV in Thailand

Who this might be right for
HIV InfectionsPregnancy
Institut de Recherche pour le Developpement 1,792
Next Page